Recent News

• 06.04.2026 - Advancing Gene Therapy Innovation in Ophthalmology Trials
• 06.01.2026 - Expert Perspectives on the Transforming Diabetes Clinical Trial Landscape
• 05.27.2026 - Inside the Lab: Building Histology Capabilities for Modern Clinical Trials – Q&A with Rob McGee, MD, PhD
• 05.26.2026 - Q&A with Medpace’s Two New Neurology Experts
• 05.21.2026 - Raising The Standard in Pediatric Migraine Clinical Trials
• 05.21.2026 - Key Highlights from Digestive Disease Week 2026
• 05.18.2026 - Q&A With New Medical Expert: Dr. Jack Bleesing, MD, PhD
• 05.04.2026 - ASN Kidney Week: Transformative Nephrology Insights
• 04.29.2026 - What’s Next for ID&V? Clinical Development Trends from ESCMID Global 2026

Recent Filings

• 06.04.2026 - 8-K Current report
• 06.04.2026 - 3 Initial statement of beneficial ownership of securities
• 06.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.28.2026 - 144 Report of proposed sale of securities
• 05.19.2026 - 8-K Current report
• 05.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.18.2026 - 4 Statement of changes in beneficial ownership of securities